Incyte to Present at Upcoming Investor Conference

Rhea-AI Summary

Incyte (Nasdaq:INCY) announced its participation in the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 11:45 a.m. ET. The presentation will be available via a live webcast, and a replay will be accessible for 90 days afterward.

Incyte, a biopharmaceutical company based in Wilmington, Delaware, focuses on addressing significant unmet medical needs through innovative therapeutics. For further details, visit Incyte.com.

Incyte (Nasdaq:INCY) announced today that it will present at the Morgan Stanley 19^th Annual Global Healthcare Conference (Virtual) on Monday, September 13, 2021 at 11:45 a.m. ET.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 90 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005012/en/

FAQ

What is the date of Incyte's presentation at the Morgan Stanley Healthcare Conference?

Incyte's presentation is scheduled for September 13, 2021.

What time will Incyte present at the Morgan Stanley Conference?

Incyte's presentation will take place at 11:45 a.m. ET.

Where can I watch Incyte's presentation at the conference?

The presentation can be accessed live at Investor.Incyte.com.

How long will the Incyte presentation be available for replay?

The presentation will be available for replay for 90 days.

What is the focus of Incyte as a biopharmaceutical company?

Incyte focuses on discovering and developing proprietary therapeutics for serious unmet medical needs.